Research Lab Results
-
Drug Discovery Group
Barbara Slusher, M.A.S., Ph.D., leads a 20-member veteran drug discovery team of medicinal chemists, assay developers, pharmacologists, toxicologists and pharmacokinetic/drug metabolism experts, who identify novel drug targets arising from JHU faculty’s research and translate them into new, small molecule drug therapies. Her team collaborates extensively with faculty at the Bloomberg~Kimmel Institute for Cancer Immunotherapy and leads the BKI immunotherapy drug discovery core, aimed at developing new immune-targeting drug therapies for laboratory and clinical testing at Johns Hopkins. -
The mission of the Lemberg research group is to understand metabolism in childhood/young adult cancers in order to develop a better understanding of how these cancers develop, how they respond to treatments, and how children can go on to live healthy lives with or after a cancer history. We aim to investigate how tumors and the surrounding physiologic environments interact to drive nutrient use so that the tumor can grow and spread, and how the presence of a cancer affects the development of the whole child. Our ultimate goal is to improve outcomes for children and young adults with cancer.